Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 28, 2025 | (Q1)Jun 29, 2025 | (FY)Mar 30, 2025 | (Q4)Mar 30, 2025 | (Q3)Dec 29, 2024 | (Q2)Sep 29, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.79%272.6M | 22.36%107.8M | 1.09%1.35B | 7.43%384.6M | -0.33%607.9M | -4.73%267.8M | 3.89%88.1M | 9.60%1.33B | 22.10%358M | 609.9M |
| Operating revenue | 1.79%272.6M | 22.36%107.8M | 1.09%1.35B | 7.43%384.6M | -0.33%607.9M | -4.73%267.8M | 3.89%88.1M | 9.60%1.33B | 22.10%358M | --609.9M |
| Cost of revenue | -1.16%102.5M | 17.18%41.6M | -2.67%405.3M | -11.84%110.2M | -2.68%155.9M | 2.07%103.7M | 19.93%35.5M | 3.63%416.4M | 21.48%125M | 160.2M |
| Gross profit | 3.66%170.1M | 25.86%66.2M | 2.80%943.1M | 17.77%274.4M | 0.51%452M | -8.58%164.1M | -4.71%52.6M | 12.54%917.4M | 22.44%233M | 449.7M |
| Operating expense | 15.51%187.7M | 50.43%224.9M | -1.75%779M | 4.48%219.3M | -1.28%247.7M | -8.30%162.5M | -3.49%149.5M | 18.77%792.9M | 21.54%209.9M | 250.9M |
| Selling and administrative expenses | 15.51%187.7M | 50.43%224.9M | -1.75%779M | 4.48%219.3M | -1.28%247.7M | -8.30%162.5M | -3.49%149.5M | 18.77%792.9M | 21.54%209.9M | --250.9M |
| Operating profit | -1,200.00%-17.6M | -63.78%-158.7M | 31.81%164.1M | 138.53%55.1M | 2.77%204.3M | -30.43%1.6M | 2.81%-96.9M | -15.65%124.5M | 31.25%23.1M | 198.8M |
| Net non-operating interest income (expenses) | 12.82%-10.2M | 21.78%-7.9M | 5.20%-40.1M | 18.63%-8.3M | 11.50%-10M | -4.46%-11.7M | -5.21%-10.1M | -24.41%-42.3M | -12.09%-10.2M | -11.3M |
| Non-operating interest income | 100.00%600K | 433.33%1.6M | 115.38%2.8M | 375.00%1.9M | 200.00%300K | 200.00%300K | -57.14%300K | 44.44%1.3M | -20.00%400K | --100K |
| Non-operating interest expense | -16.38%9.7M | -9.09%9M | -0.97%41M | -5.94%9.5M | -7.41%10M | 8.41%11.6M | 1.02%9.9M | 28.97%41.4M | 17.44%10.1M | --10.8M |
| Total other finance cost | 175.00%1.1M | 0.00%500K | -13.64%1.9M | 40.00%700K | -50.00%300K | -33.33%400K | 0.00%500K | -21.43%2.2M | -50.00%500K | --600K |
| Other net income (expenses) | -140.63%-1.3M | -63.77%2.5M | 163.08%4.1M | -139.53%-1.7M | -22.86%-4.3M | 233.33%3.2M | 240.82%6.9M | 67.66%-6.5M | 132.82%4.3M | -3.5M |
| Gain on sale of security | -200.00%-2.1M | 163.16%2.4M | -224.32%-12M | -139.17%-4.7M | -3.70%-5.6M | 147.73%2.1M | 35.59%-3.8M | 83.91%-3.7M | 218.81%12M | ---5.4M |
| Special income (charges) | -27.27%800K | -99.07%100K | 675.00%16.1M | 138.96%3M | -31.58%1.3M | -45.00%1.1M | 970.00%10.7M | -196.55%-2.8M | -156.67%-7.7M | --1.9M |
| -Less:Restructuring and mergern&acquisition | 27.27%-800K | 99.07%-100K | -675.00%-16.1M | -138.96%-3M | 31.58%-1.3M | 45.00%-1.1M | -970.00%-10.7M | 196.55%2.8M | 156.67%7.7M | ---1.9M |
| Income before tax | -321.74%-29.1M | -63.94%-164.1M | 69.22%128.1M | 162.21%45.1M | 3.26%190M | 38.94%-6.9M | 12.35%-100.1M | -19.04%75.7M | 473.91%17.2M | 184M |
| Income tax | 11.36%-11.7M | -47.89%-38.6M | 39.20%24.5M | 81.25%17.4M | -11.79%46.4M | 14.29%-13.2M | 10.62%-26.1M | -28.46%17.6M | 77.78%9.6M | 52.6M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -376.19%-17.4M | -69.59%-125.5M | 78.31%103.6M | 264.47%27.7M | 9.28%143.6M | 53.66%6.3M | 12.94%-74M | -15.67%58.1M | 176.00%7.6M | 131.4M |
| Net income continuous operations | -376.19%-17.4M | -69.59%-125.5M | 78.31%103.6M | 264.47%27.7M | 9.28%143.6M | 53.66%6.3M | 12.94%-74M | -15.67%58.1M | 176.00%7.6M | --131.4M |
| Noncontrolling interests | -344.44%-2.2M | -108.82%-300K | 3,033.33%8.8M | -76.92%600K | 387.50%3.9M | 350.00%900K | 187.18%3.4M | 92.11%-300K | 137.68%2.6M | 800K |
| Net income attributable to the company | -381.48%-15.2M | -61.76%-125.2M | 62.33%94.8M | 442.00%27.1M | 6.97%139.7M | 38.46%5.4M | 4.56%-77.4M | -19.67%58.4M | 261.29%5M | 130.6M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -381.48%-15.2M | -61.76%-125.2M | 62.33%94.8M | 442.00%27.1M | 6.97%139.7M | 38.46%5.4M | 4.56%-77.4M | -19.67%58.4M | 261.29%5M | 130.6M |
| Diluted earnings per share | -366.67%-0.16 | -61.25%-1.29 | 68.97%0.98 | 366.67%0.28 | 10.77%1.44 | 50.00%0.06 | -2.56%-0.8 | -15.94%0.58 | 300.00%0.06 | 1.3 |
| Basic earnings per share | -366.67%-0.16 | -61.25%-1.29 | 70.18%0.97 | 460.00%0.28 | 10.08%1.42 | 50.00%0.06 | -2.56%-0.8 | -17.39%0.57 | 266.67%0.05 | 1.29 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.